Heartburn pills ‘can raise osteoporosis risk’
May 29th, 2010 - 2:21 pm ICT by ANILondon, May 29 (ANI): Heartburn pills can lead to more than one bargained for - the drugs have been linked to an increased risk of the bone disease osteoporosis.
According to a research, the meds used by millions of patients to treat indigestion and heartburn, called proton pump inhibitors (PPIs), are linked with broken bones later in life.
Back in 2006, University of Pennsylvania researchers found that patients taking PPIs for more than a year were 44 per cent more likely to suffer a hip fracture.
And in 2008 a team at the University of Manitoba in Canada found a similar increase in risk among those taking the drugs regularly for five years, reports The Daily Express.
Rob Dawson, of the National Osteoporosis Society, said: “All drugs carry some risks so you have to weigh them against the overall benefits.” (ANI)
- Heartburn pills may cause osteoporosis - May 30, 2010
- Fracture prone? Blame your genes - Apr 22, 2012
- Indigestion drugs can up brittle bone risk - Aug 17, 2008
- FDA warns of fractures with prolonged usage of heartburn drugs - May 26, 2010
- Jab hope for osteoporosis sufferers - Jun 18, 2010
- Gene combinations linked to hip osteoporosis in postmenopausal women - Mar 30, 2011
- Heartburn Drugs Can Cause Fractures - May 26, 2010
- Thinning of bones linked to heart failure - Feb 03, 2012
- Drug counters bone-damaging effects of breast cancer medication - Oct 10, 2011
- Elderly can blame low sodium for fractures and falls - Nov 21, 2010
- Proton pump inhibitor use in reflux disease may lead to unexpected consequences - Nov 02, 2009
- Long-term use of osteoporosis drugs raises risk of fractures - Feb 23, 2011
- Heartburn drugs increase risk of hip fractures - Jun 05, 2009
- Obese kids at greater risk of bone fractures and osteoporosis in old age - Apr 11, 2011
- New gene could trigger osteoporosis - Oct 05, 2011
Tags: bone disease, broken bones, canada, daily express, dawson, disease osteoporosis, drugs, hip fracture, indigestion, london, meds, national osteoporosis society, osteoporosis, osteoporosis risk, pennsylvania researchers, pills, ppis, proton pump inhibitors, university of manitoba, university of pennsylvania